Cis-dichlorodiammineplatinum (II) and VP 16–213 combination chemotherapy for non-small cell lung cancer-Reference-Cited by-同舟云学术

Cis-dichlorodiammineplatinum (II) and VP 16–213 combination chemotherapy for non-small cell lung cancer

Published:1981 Issue:3 Volume:9 Page:205-208
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Goldhirsch Aron,Joss Rudolf A.,Cavalli Franco,Sonntag Roland W.,Brunner Kurt W.

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology and Child Health

Reference6 articles.

1. Etoposide (VP-16-213)

2. : Therapeutic synergism in murine tumors for combinations of cis-dichloro-diammineplatinum with VP 16–213or BCNU. Proc Amer Ass Cancer Res.

3. Belgian EORTC Lung Cancer Working Party: Combination chemotherapy with cisplatin and VP 16 in non-small cell bronchogenic carcinoma: Abstracts II World Conference on Lung Cancer, 116, Amsterdam, Oxford, Princeton: Excerpta Medica, 1980.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy dose–response relationships in non-small cell lung cancer and implied resistance mechanisms;Cancer Treatment Reviews;2007-04

2. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97–12;International Journal of Radiation Oncology*Biology*Physics;2005-06

3. A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers;Lung Cancer;2003-11

4. Intrapleural Administration of Cisplatin and Etoposide to Treat Malignant Pleural Effusions in Patients with Non-Small Cell Lung Cancer;Chemotherapy;1999

5. The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC);Annals of Oncology;1999